GSK 224876

SKU T27442-25 mg Category Small Compound Brand: TargetMol

Price range: 2,672 CAD through 4,480 CAD

Size

100 mg 25 mg 50 mg

Clear

Products Details

Product Description

– GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects.

Web ID

– T27442

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C20H17ClN3O3P

References

– Margolis DA, Eron JJ, DeJesus E, White S, Wannamaker P, Stancil B, Johnson M. Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761). Antivir Ther. 2014;19(1):69-78. doi: 10.3851/IMP2689. Epub 2013 Oct 24. PubMed PMID: 24158593.

CAS Number

– 1097733-15-7

Molecular Weight

– C20H17ClN3O3P

SMILES

– CC1=CC(P(C2=C(C(N)=O)NC3=CC=C(Cl)C=C23)(OC)=O)=CC(/C=C/C#N)=C1

Pathway

– Others

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

GSK 224876

Products Details

A-Z PRODUCTS

POPULAR PRODUCTS

Help & Support

Compare Products (0 Products)

GSK 224876

Products Details

Related Products

Request Data Sheet / Safty Data Sheet

Price Request